Treatment of the postoperative recurrence of lung cancer in octogenarians.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 24026198)

Published in Surg Today on September 12, 2013

Authors

Manabu Yasuda1, Akira Nagashima, Akira Haro, Genkichi Saitoh

Author Affiliations

1: Department of Chest Surgery, Kitakyushu Municipal Medical Center, 2-1-1 Basyaku, Kokurakita-ku, Kitakyushu, 802-0077, Japan, ikyoku189@kmmc.jp.

Articles cited by this

Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med (2002) 24.87

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol (2008) 17.30

Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol (2008) 3.83

Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol (2007) 3.50

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol (2008) 3.03

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol (2005) 2.98

Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol (2007) 2.57

Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg (2007) 2.23

Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.66

Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer (2007) 1.53

Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol (2007) 1.48

Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol (2011) 1.45

Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg (2006) 1.07

Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients. J Thorac Oncol (2007) 1.01

Lung cancer in octogenarians. J Thorac Oncol (2010) 1.01

A phase II trial of gefitinib monotherapy in chemotherapy-naïve patients of 75 years or older with advanced non-small cell lung cancer. J Thorac Oncol (2008) 0.94

Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today (2012) 0.93

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol (2011) 0.93

Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6. J Thorac Oncol (2007) 0.90

A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). Br J Cancer (2011) 0.89

Surgical treatment of lung cancer in the octogenarian. Ann Thorac Surg (1994) 0.88

Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors. J Thorac Oncol (2010) 0.82

Results of surgical treatment of lung cancer in octogenarians. Lung Cancer (1999) 0.80

Do elderly people with lung cancer benefit from palliative radiotherapy? Lung Cancer (2005) 0.80

A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older. Lung Cancer (2003) 0.79

Articles by these authors

Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy. Chest (2002) 1.59

Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer (2008) 1.20

Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features. Int J Clin Oncol (2011) 1.06

Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer (2004) 1.05

Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer. Ann Thorac Surg (2010) 1.05

Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer. J Surg Oncol (2010) 1.03

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance. Ann Thorac Surg (2004) 0.98

Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan. Lung Cancer (2008) 0.97

Aspergilloma mimicking a lung cancer. Int J Surg Case Rep (2013) 0.87

Primary pulmonary Ewing's sarcoma: report of a case. Surg Today (2012) 0.86

Pneumonectomy for non-small cell lung cancer. Surg Today (2012) 0.85

Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size. J Thorac Oncol (2010) 0.85

Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer. Lung Cancer (2013) 0.84

Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer. Anticancer Res (2012) 0.84

A unique method for repairing intraoperative pulmonary air leakage with both polyglycolic acid sheets and fibrin glue. World J Surg (2012) 0.81

Intramolecular cyclization with nitrenium ions generated by treatment of N-acylaminophthalimides with hypervalent iodine compounds: formation of lactams and spiro-fused lactams. J Org Chem (2003) 0.81

Clinical characterization of node-negative lung adenocarcinoma: results of a prospective investigation. J Thorac Oncol (2006) 0.80

Differences in the expression of epithelial-mesenchymal transition related molecules between primary tumors and pulmonary metastatic tumors in colorectal cancer. Surg Today (2012) 0.80

Lung cancer associated with diffuse pulmonary fibrosis: CT-pathologic correlation. J Thorac Imaging (2003) 0.79

Genetic alteration in carcinoid tumors of the lung. Ann Thorac Cardiovasc Surg (2003) 0.78

Association between EGFR-TKI resistance and efficacy of radiotherapy for brain metastases from EGFR-mutant lung adenocarcinoma. Anticancer Res (2013) 0.78

[Long-term survival after surgical resection of bone metastasis from lung cancer]. Kyobu Geka (2010) 0.78

[Multimodality therapy containing hepatic arterial infusion chemotherapy for liver metastasis of esophageal cancer-a case report]. Gan To Kagaku Ryoho (2012) 0.77

Hemangioma in the anterior mediastinum. Jpn J Thorac Cardiovasc Surg (2003) 0.77

Assessing a clinical pathway to improve the quality of care in pulmonary resections. Surg Today (2011) 0.76

Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. Bioorg Med Chem (2012) 0.76

Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment. Bioorg Med Chem (2013) 0.76

Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2. Bioorg Med Chem (2013) 0.76

A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer. Anticancer Res (2010) 0.76

The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma. Surg Today (2011) 0.76

Utility of preoperative visualization for intrapulmonary sequestration in video-assisted thoracoscopic surgery. Int J Surg Case Rep (2011) 0.75

Analysis of the surgical treatment for superior sulcus tumors. Surg Today (2012) 0.75

Carcinoid tumors of the lung: a report of 11 cases. Asian J Surg (2013) 0.75

[Chest surgery in patients with pulmonary metastasis from head and neck cancer]. Kyobu Geka (2013) 0.75

[Resected Pulmonary Cryptococcosis Suspected as Lung Cancer;Report of a Case]. Kyobu Geka (2015) 0.75

Operation for tracheal bronchus: 3-dimensional reconstruction imaging. Ann Thorac Surg (2011) 0.75

[Delayed massive hemothorax due to diaphragmatic injury by lower rib fracture]. Kyobu Geka (2010) 0.75

Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer. Anticancer Res (2010) 0.75

Development of a pumping laser system for x-ray laser research. Appl Opt (2003) 0.75

[Chest wall reconstruction with rectus abdominis musculocutaneous flap for sternum osteomyelitis after radiation]. Kyobu Geka (2012) 0.75